Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report Forecast 2017-2021

1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview

1.1 Product Overview and Scope of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

1.2 Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

1.2.1 Type 1

1.2.2 Type 2

1.2.3 Type 3

1.3 Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

1.3.2 Application 1

1.3.3 Application 2

1.3.4 Application 3

1.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market States Status and Prospect (2012-2021) by Countries

1.4.1 Germany

1.4.2 France

1.4.3 UK

1.4.4 Russia

1.4.5 Italy

1.4.6 Spain

1.4.7 Benelux

1.5 Europe Market Size (Value and Volume) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug (2012-2021)

1.5.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2021)

1.5.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)

2 Europe Economic Impact on Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry

2.1 Europe Macroeconomic Analysis

2.2 Europe Macroeconomic Environment Development Trend

3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Cost Analysis

3.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Raw Materials Analysis

3.1.1 Key Raw Materials

3.1.2 Price Trend of Key Raw Materials

3.1.3 Key Suppliers of Raw Materials

3.1.4 Market Concentration Rate of Raw Materials

3.2 Proportion of Manufacturing Cost Structure

3.2.1 Raw Materials

3.2.2 Labor Cost

3.2.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

4 Industrial Chain, Sourcing Strategy and Downstream Buyers

4.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis

4.2 Upstream Raw Materials Sourcing

4.3 Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015

4.4 Downstream Buyers

5 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis by Manufacturers, Type and Application

5.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competition by Manufacturers

5.1.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share of Key Manufacturers (2015 and 2016)

5.1.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Share by Manufacturers (2015 and 2016)

5.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Type

5.2.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2012-2017)

5.2.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2012-2017)

5.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Countries

5.3.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Countries (2012-2017)

5.3.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Countries (2012-2017)

5.4 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume) by Application

6 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)

6.1 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)

6.1.1 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

6.1.2 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

6.1.3 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

6.2 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers

6.3 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type

6.4 Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

7 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)

7.1 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)

7.1.1 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

7.1.2 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

7.1.3 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

7.2 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers

7.3 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type

7.4 France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

8 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)

8.1 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)

8.1.1 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

8.1.2 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

8.1.3 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

8.2 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers

8.3 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type

8.4 UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

9 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)

9.1 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)

9.1.1 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

9.1.2 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

9.1.3 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

9.2 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers

9.3 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type

9.4 Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

10 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)

10.1 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)

10.1.1 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

10.1.2 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

10.1.3 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

10.2 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers

10.3 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type

10.4 Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

11 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)

11.1 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)

11.1.1 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

11.1.2 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

11.1.3 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

11.2 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers

11.3 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type

11.4 Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

12 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)

12.1 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)

12.1.1 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

12.1.2 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

12.1.3 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

12.2 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers

12.3 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type

12.4 Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

13 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturers Analysis

13.1 Conatus Pharmaceuticals

13.1.1 Company Basic Information, Manufacturing Base and Competitors

13.1.2 Product Type, Application and Specification

13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.1.4 Business Overview

13.2 Daewoong Pharmaceutical

13.2.1 Company Basic Information, Manufacturing Base and Competitors

13.2.2 Product Type, Application and Specification

13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.2.4 Business Overview

13.3 Galmed International

13.3.1 Company Basic Information, Manufacturing Base and Competitors

13.3.2 Product Type, Application and Specification

13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.3.4 Business Overview

13.4 Kyorin Pharmaceutical

13.4.1 Company Basic Information, Manufacturing Base and Competitors

13.4.2 Product Type, Application and Specification

13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.4.4 Business Overview

13.5 Metabolic Solutions Development

13.5.1 Company Basic Information, Manufacturing Base and Competitors

13.5.2 Product Type, Application and Specification

13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.5.4 Business Overview

13.6 Novartis AG

13.6.1 Company Basic Information, Manufacturing Base and Competitors

13.6.2 Product Type, Application and Specification

13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.6.4 Business Overview

13.7 Phenex Pharmaceuticals

13.7.1 Company Basic Information, Manufacturing Base and Competitors

13.7.2 Product Type, Application and Specification

13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.7.4 Business Overview

13.8 Raptor Pharmaceuticals

13.8.1 Company Basic Information, Manufacturing Base and Competitors

13.8.2 Product Type, Application and Specification

13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.8.4 Business Overview

13.9 TCM Biotech International

13.9.1 Company Basic Information, Manufacturing Base and Competitors

13.9.2 Product Type, Application and Specification

13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.9.4 Business Overview

…

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Market Effect Factors Analysis

14.1 Technology Progress/Risk

14.1.1 Substitutes Threat

14.1.2 Technology Progress in Related Industry

14.2 Consumer Needs/Customer Preference Change

14.3 Economic/Political Environmental Change

15 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Forecast (2017-2021)

15.1 Germany Market Forecast (2017-2021)

15.2 France Market Forecast (2017-2021)

15.3 UK Market Forecast (2017-2021)

15.4 Russia Market Forecast (2017-2021)

15.5 Italy Market Forecast (2017-2021)

15.6 Spain Market Forecast (2017-2021)

15.7 Benelux Market Forecast (2017-2021)

15.8 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Forecast by Type (2017-2021)

15.9 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Forecast by Application (2017-2021)

16 Appendix

Table Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Figure Europe Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2015

Table Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Figure Europe Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application in 2015

Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)

Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)

Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)

Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)

Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)

Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)

Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)

Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2021)

Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales of Key Manufacturers (2015 and 2016)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers

Figure 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue by Manufacturers (2015 and 2016)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers

Table 2016 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2012-2017)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Type (2012-2017)

Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2012-2017)

Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Growth Rate by Type (2012-2017)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2012-2017)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2012-2017)

Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Growth Rate by Type (2012-2017)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Countries (2012-2017)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Countries (2012-2017)

Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Countries (2012-2017)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Countries (2012-2017)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Countries (2012-2017)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application (2012-2017)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Application (2012-2017)

Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application (2012-2017)

Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)

Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)

Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)

Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)

Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)

Table Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)

Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)

Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)

Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)

Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)

Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)

Table France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)

Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)

Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)

Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)

Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)

Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)

Table UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)

Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)

Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)

Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)

Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)

Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)

Table Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)

Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)

Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)

Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)

Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)

Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)

Table Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)

Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)

Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)

Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)

Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)

Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)

Table Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)

Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2015 and 2016)

Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2015 and 2016)

Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2015 and 2016)

Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2015 and 2016)

Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2015 and 2016)

Table Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2015 and 2016)

Table Conatus Pharmaceuticals Basic Information List

Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)

Table Daewoong Pharmaceutical Basic Information List

Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)

Table Galmed International Basic Information List

Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)

Table Kyorin Pharmaceutical Basic Information List

Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)

Table Metabolic Solutions Development Basic Information List

Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)

Table Novartis AG Basic Information List

Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)

Table Phenex Pharmaceuticals Basic Information List

Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)

Table Raptor Pharmaceuticals Basic Information List

Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017)

Table TCM Biotech International Basic Information List

Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share (2012-2017).

…

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Figure Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis

Table Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015

Table Major Buyers of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Table Distributors/Traders List

Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2021)

Figure Germany Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2021)

Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2021)

Figure France Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2021)

Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2021)

Figure UK Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2021)

Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2021)

Figure Russia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2021)

Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2021)

Figure Italy Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2021)

Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2021)

Figure Spain Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2021)

Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2021)

Figure Benelux Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2021)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Type (2017-2021)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Application (2017-2021)